RAF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.660620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.815220E-01
Normal-vs-Stage2
2.100600E-01
Normal-vs-Stage3
2.460200E-02
Normal-vs-Stage4
4.051800E-01
Stage1-vs-Stage2
4.191000E-01
Stage1-vs-Stage3
2.159000E-01
Stage1-vs-Stage4
3.397200E-01
Stage2-vs-Stage3
2.087800E-02
Stage2-vs-Stage4
6.041000E-01
Stage3-vs-Stage4
1.974200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.685180E-01
Normal-vs-AfricanAmerican
3.974400E-01
Normal-vs-Asian
2.125600E-01
Caucasian-vs-AfricanAmerican
8.201200E-01
Caucasian-vs-Asian
6.125000E-01
AfricanAmerican-vs-Asian
6.776800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.602200E-01
Normal-vs-Female
1.845560E-01
Male-vs-Female
5.059800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.111800E-01
Normal-vs-Age(41-60Yrs)
3.391800E-01
Normal-vs-Age(61-80Yrs)
1.143170E-01
Normal-vs-Age(81-100Yrs)
9.875900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.486600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.385400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.496200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.523900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.106800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.251200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.432790E-01
Normal-vs-Daily Drinker
1.658370E-01
Normal-vs-Weekly Drinker
4.100400E-01
Normal-vs-Occasional Drinker
1.617180E-01
Normal-vs-Social Drinker
1.168810E-01
Non Drinker-vs-Daily Drinker
9.555600E-01
Non Drinker-vs-Weekly Drinker
4.513000E-01
Non Drinker-vs-Occasional Drinker
5.092400E-01
Non Drinker-vs-Social Drinker
6.818600E-01
Daily Drinker-vs-Weekly Drinker
5.115000E-01
Daily Drinker-vs-Occasional Drinker
5.691000E-01
Daily Drinker-vs-Social Drinker
7.351800E-01
Weekly Drinker-vs-Occasional Drinker
8.208200E-01
Weekly Drinker-vs-Social Drinker
6.992600E-01
Occasional Drinker-vs-Social Drinker
8.130400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.731600E-01
Normal-vs-Grade 2
8.858600E-01
Normal-vs-Grade 3
8.693800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.180500E-03
Grade 1-vs-Grade 3
5.263300E-03
Grade 1-vs-Grade 4
9.731600E-01
Grade 2-vs-Grade 3
6.157800E-01
Grade 2-vs-Grade 4
8.858600E-01
Grade 3-vs-Grade 4
8.693800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.570590E-01
Normal-vs-NonDiabetic
1.433960E-01
Diabetic-vs-NonDiabetic
9.763400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.393400E-01
Normal-vs-NoPancreatitis
1.254980E-01
Pancreatitis-vs-NoPancreatitis
1.032990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.075160E-01
Normal-vs-N1
2.096200E-01
N0-vs-N1
1.789190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.755800E-01
Normal-vs-TP53-NonMutant
2.135600E-01
TP53-Mutant-vs-TP53-NonMutant
3.800200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
